UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response:
0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
1. Name and Address of Reporting Person*BRANDICOURT OLIVIER
(Last)
(First)
(Middle)
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
(Street)
NEW YORK
NY
10017
(City)
(State)
(Zip)
2. Issuer Name and Ticker or Trading Symbol
PFIZER INC
[ PFE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director
10% Owner
Officer (give title below)
Other (specify below)
Business Unit President
3. Date of Earliest Transaction
(Month/Day/Year)
02/28/2013
4. If Amendment, Date of Original Filed
(Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
3)
2. Transaction Date
(Month/Day/Year)
2A. Deemed Execution Date, if any
(Month/Day/Year)
3. Transaction Code (Instr.
8)
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
7. Nature of Indirect Beneficial Ownership (Instr.
4)
Code
Amount
(A) or (D)
Price
Common Stock
02/28/2013
47,189(1)
$22.55
299,974
Common Stock
02/28/2013
44,325(2)
$0.0000
344,299
Common Stock
02/28/2013
26,080(3)
$0.0000
370,379
Common Stock
02/28/2013
24,743(4)
$27.37
345,636
Common Stock
02/28/2013
41,196(5)
$27.37
304,440
Common Stock
11,184
By Rule 16b-3 Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
3)
2. Conversion or Exercise Price of Derivative Security
3. Transaction Date
(Month/Day/Year)
3A. Deemed Execution Date, if any
(Month/Day/Year)
4. Transaction Code (Instr.
8)
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
8. Price of Derivative Security (Instr.
5)
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
11. Nature of Indirect Beneficial Ownership (Instr.
4)
Code
(A)
(D)
Date Exercisable
Expiration Date
Title
Amount or Number of Shares
Stock Appreciation Rights
$22.55
02/28/2013
40,629(6)
02/28/2013(7)
02/28/2013(7)
Common Stock
40,629
$0.0000
0.0000
Stock Appreciation Rights
$27.37
02/28/2013
154,185
02/28/2018(8)
02/28/2018(8)
Common Stock
154,185
$0.0000
154,185
Stock Appreciation Rights
$27.37
02/28/2013
127,971
02/28/2020(9)
02/28/2020(9)
Common Stock
127,971
$0.0000
127,971
Explanation of Responses:
1. The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
2. The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
3. The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
4. The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
5. The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon).
6. Dividend equivalents are paid on these stock appreciation rights at the time of settlement.
7. The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
8. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
9. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
Lawrence A. Fox, by power of atty., for Olivier Brandicourt
03/04/2013
** Signature of Reporting Person
Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person,
see
Instruction
(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.